DE69930294D1 - Minimale promotoren und ihre verwendung - Google Patents

Minimale promotoren und ihre verwendung

Info

Publication number
DE69930294D1
DE69930294D1 DE69930294T DE69930294T DE69930294D1 DE 69930294 D1 DE69930294 D1 DE 69930294D1 DE 69930294 T DE69930294 T DE 69930294T DE 69930294 T DE69930294 T DE 69930294T DE 69930294 D1 DE69930294 D1 DE 69930294D1
Authority
DE
Germany
Prior art keywords
reagents
promoters
minimum
minimum promoters
methods
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69930294T
Other languages
English (en)
Other versions
DE69930294T2 (de
Inventor
T Fuller
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Powderject Vaccines Inc
Original Assignee
Powderject Vaccines Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22302848&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE69930294(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Powderject Vaccines Inc filed Critical Powderject Vaccines Inc
Publication of DE69930294D1 publication Critical patent/DE69930294D1/de
Application granted granted Critical
Publication of DE69930294T2 publication Critical patent/DE69930294T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/29—Hepatitis virus
    • A61K39/292—Serum hepatitis virus, hepatitis B virus, e.g. Australia antigen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00—Reverse transcribing DNA viruses
    • C12N2730/00011—Details
    • C12N2730/10011—Hepadnaviridae
    • C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Oncology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • AIDS & HIV (AREA)
  • Transplantation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Fats And Perfumes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Saccharide Compounds (AREA)
  • Seeds, Soups, And Other Foods (AREA)
  • Confectionery (AREA)
DE1999630294 1998-10-19 1999-10-19 Minimale promotoren und ihre verwendung Expired - Lifetime DE69930294T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US10487198P 1998-10-19 1998-10-19
US104871P 1998-10-19
PCT/US1999/024694 WO2000023592A2 (en) 1998-10-19 1999-10-19 Minimal promoters and uses thereof

Publications (2)

Publication Number Publication Date
DE69930294D1 true DE69930294D1 (de) 2006-05-04
DE69930294T2 DE69930294T2 (de) 2006-11-02

Family

ID=22302848

Family Applications (1)

Application Number Title Priority Date Filing Date
DE1999630294 Expired - Lifetime DE69930294T2 (de) 1998-10-19 1999-10-19 Minimale promotoren und ihre verwendung

Country Status (14)

Country Link
US (1) US20070009487A1 (de)
EP (1) EP1123396B1 (de)
JP (1) JP2002527527A (de)
AT (1) ATE319826T1 (de)
AU (1) AU766005B2 (de)
CA (1) CA2347369A1 (de)
CY (1) CY1105034T1 (de)
DE (1) DE69930294T2 (de)
DK (1) DK1123396T3 (de)
ES (1) ES2259846T3 (de)
IL (2) IL142680A0 (de)
NZ (1) NZ511798A (de)
PT (1) PT1123396E (de)
WO (1) WO2000023592A2 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60017165T2 (de) 1999-10-11 2006-01-12 Felton International, Inc., Lenexa Universelle antiinfektionsschutzvorrichtung für nadellose injektoren
US7887506B1 (en) 1999-11-23 2011-02-15 Pulse Needlefree Systems, Inc. Safety mechanism to prevent accidental patient injection and methods of same
NZ546554A (en) * 2003-10-10 2009-04-30 Powderject Vaccines Inc Nucleic acid constructs
US20240123086A1 (en) * 2021-02-24 2024-04-18 University Of Massachusetts Inducible single aav system and uses thereof

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5036006A (en) * 1984-11-13 1991-07-30 Cornell Research Foundation, Inc. Method for transporting substances into living cells and tissues and apparatus therefor
US5100792A (en) * 1984-11-13 1992-03-31 Cornell Research Foundation, Inc. Method for transporting substances into living cells and tissues
US4945050A (en) * 1984-11-13 1990-07-31 Cornell Research Foundation, Inc. Method for transporting substances into living cells and tissues and apparatus therefor
US4629782A (en) * 1984-12-21 1986-12-16 Syntex (U.S.A.) Inc. Crystalline form of N-acetylmuramyl-L-α-aminobutyryl-D-isoglutamine
US5168062A (en) * 1985-01-30 1992-12-01 University Of Iowa Research Foundation Transfer vectors and microorganisms containing human cytomegalovirus immediate-early promoter-regulatory DNA sequence
US4980286A (en) * 1985-07-05 1990-12-25 Whitehead Institute For Biomedical Research In vivo introduction and expression of foreign genetic material in epithelial cells
US5047237A (en) * 1985-09-06 1991-09-10 Prutech Research And Development Partnership Attenuated pseudorabies virus having a deletion of at least a portion of a gene encoding an antigenic, nonessential protein, vaccine containing same and methods of identifying animals vaccinated with the vaccine
US5120657A (en) * 1986-12-05 1992-06-09 Agracetus, Inc. Apparatus for genetic transformation
US5219740A (en) * 1987-02-13 1993-06-15 Fred Hutchinson Cancer Research Center Retroviral gene transfer into diploid fibroblasts for gene therapy
GB8717430D0 (en) * 1987-07-23 1987-08-26 Celltech Ltd Recombinant dna product
US5179022A (en) * 1988-02-29 1993-01-12 E. I. Du Pont De Nemours & Co. Biolistic apparatus for delivering substances into cells and tissues in a non-lethal manner
US5703055A (en) * 1989-03-21 1997-12-30 Wisconsin Alumni Research Foundation Generation of antibodies through lipid mediated DNA delivery
EP0500799B1 (de) * 1989-11-16 1998-01-14 Duke University Transformation von tierischen Hautzellen mit hilfe von Partikeln
US5091188A (en) * 1990-04-26 1992-02-25 Haynes Duncan H Phospholipid-coated microcrystals: injectable formulations of water-insoluble drugs
US5204253A (en) * 1990-05-29 1993-04-20 E. I. Du Pont De Nemours And Company Method and apparatus for introducing biological substances into living cells
US5149655A (en) * 1990-06-21 1992-09-22 Agracetus, Inc. Apparatus for genetic transformation
US5558644A (en) * 1991-07-16 1996-09-24 Heartport, Inc. Retrograde delivery catheter and method for inducing cardioplegic arrest
US5658892A (en) * 1993-01-15 1997-08-19 The General Hospital Corporation Compound delivery using high-pressure impulse transients
TW360548B (en) * 1993-04-08 1999-06-11 Powderject Res Ltd Products for therapeutic use
US5888981A (en) * 1993-06-14 1999-03-30 Basf Aktiengesellschaft Methods for regulating gene expression
DE69529495T2 (de) * 1994-01-21 2003-06-12 Powderject Vaccines Inc Gasbetätigtes element zum austragen von genmaterial
US5899880A (en) * 1994-04-08 1999-05-04 Powderject Research Limited Needleless syringe using supersonic gas flow for particle delivery
GB9502879D0 (en) * 1995-02-14 1995-04-05 Oxford Biosciences Ltd Particle delivery
FR2735789B1 (fr) * 1995-06-23 1997-07-25 Centre Nat Rech Scient Adenovirus recombinants, leur utilisation pour preparer des aav, lignee cellulaire complementaire et compositions pharmaceutiques les contenant
US6013050A (en) * 1995-10-20 2000-01-11 Powderject Research Limited Particle delivery
GB9605690D0 (en) * 1996-03-19 1996-05-22 Oxford Biosciences Ltd Particle delivery
US5891718A (en) * 1996-03-27 1999-04-06 Vical Incorporated Tetracycline inducible/repressible systems
US6156567A (en) * 1996-07-03 2000-12-05 Merial Truncated transcriptionally active cytomegalovirus promoters
ATE291588T1 (de) * 1996-11-08 2005-04-15 Oklahoma Med Res Found Endothel-spezifischer expression unter einfluss von epcr kontrollelementen
WO1998037185A2 (en) * 1997-02-20 1998-08-27 The Board Of Regents Of The University Of Texas System Vectors for controlled gene expression
US6368825B1 (en) * 1998-08-10 2002-04-09 Academia Sinica Baculovirus containing minimal CMV promoter

Also Published As

Publication number Publication date
US20070009487A1 (en) 2007-01-11
EP1123396A2 (de) 2001-08-16
WO2000023592A3 (en) 2000-07-27
JP2002527527A (ja) 2002-08-27
ES2259846T3 (es) 2006-10-16
PT1123396E (pt) 2006-07-31
WO2000023592A2 (en) 2000-04-27
NZ511798A (en) 2004-01-30
WO2000023592B1 (en) 2000-09-08
DK1123396T3 (da) 2006-07-10
IL142680A0 (en) 2002-03-10
AU1707300A (en) 2000-05-08
WO2000023592A9 (en) 2000-09-28
DE69930294T2 (de) 2006-11-02
CY1105034T1 (el) 2010-03-03
IL142680A (en) 2010-04-15
CA2347369A1 (en) 2000-04-27
EP1123396B1 (de) 2006-03-08
ATE319826T1 (de) 2006-03-15
AU766005B2 (en) 2003-10-09

Similar Documents

Publication Publication Date Title
ATE551352T1 (de) Peptidakzeptorbindungsverfahren
DK0920498T3 (da) Hamster EF-1alfa transskriptionelt, regulatorisk DNA
DE69801321D1 (de) Slurrykohlenwasserstoffsyntheseverfahren mit mehrstufenkatalysatorwiederbelebung
EP0892048A3 (de) XAF Gene und Polypeptide und deren Verwendung zur Modulation der Apoptose
ES2143475T3 (es) Genes de polifenol oxidasa.
DE69816059D1 (de) Gen, das für das pyruvat dehydrogenase kinase von pflanzen kodiert
DE69739346D1 (de) Gereinigtes sr-p70 protein
ATE389018T1 (de) Cx3c chemokin-gene von säugetieren
DE69930294D1 (de) Minimale promotoren und ihre verwendung
ATE364616T1 (de) Nucleinsäuremolekül, kit und verwendung
DE69809930T2 (de) Isolierung und verwendung von nukleinsäuremolekülen, welche für mitglieder der ssx-familie kodieren
EP1038025A4 (de) Genetische veränderungen im zusammenhang mit krebs
ES2178203T3 (es) Metodos y reactivos para modular la apoptosis.
EA199801007A1 (ru) Способ биосинтеза, позволяющий получать кобаламины
ATE348109T1 (de) Das gen prv-1 und dessen verwendung
AR016145A1 (es) Citoquinas de mamifero; reactivos relacionados
DK199900148A (da) Enzym samt DNA-sekvens, der koder for dette
ATE408686T1 (de) Chondrosarcom-assoziierte gene
SE9302856D0 (sv) Method and means for producing a plasmapeotein-binding protein
MX9709596A (es) Adn catal ??tico.
ATE53608T1 (de) Test fuer nukleinsaeuresequenzen, insbesondere genetische veraenderungen.
BR1100781B1 (pt) receptor quimÉrico proteinÁceo ligado À membrana celular, dna que codifica o mesmo, bem como vetor compreendendo o referido dna.
NO981220D0 (no) Cytokrom c samt gen for dette
ITTO960044A0 (it) Orizzontamento autoportante di tipo reticolare-spaziale per costruzioni civili, industriali, rurali.
ECSP982602A (es) Citoquinas de mamiferos, reactivos relacionados

Legal Events

Date Code Title Description
8363 Opposition against the patent